184 Hypertonic Saline as a Therapeutic Adjunct for Spinal Cord Injury: A Translational, Preclinical Study Using Real-Time Blood Flow Analysis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: Secondary ischemia and edema magnify neurological damage after spinal cord injury (SCI). Hypertonic saline (HTS) rapidly reduces cerebral edema, yet its hemodynamic and functional impact on injured spinal cord has never been quantified in real time. METHODS: Adult female Sprague-Dawley rats (n=7) underwent T10 contusion (200 kdyn). A high-frequency duplex Doppler probe, fixed in a stereotactic frame, captured continuous SCBF velocity and perfused-vessel density at baseline, post-injury, and for 60 min after treatment. Animals received either 7 mL kg-1 of 7.5 % HTS (n = 4) or volume-matched 0.9 % saline (NS, n = 3) 25 min post-injury. Mean arterial pressure and end-tidal CO2 were monitored to isolate cord-specific effects. A separate survival cohort (HTS = 6, NS = 5) was followed for 25 days with Basso–Beattie–Bresnahan (BBB) scoring and daily assessment of spontaneous bladder emptying. RESULTS: HTS produced an immediate 23 ± 6 % rise in SCBF velocity that persisted for greater than 30 min (p < 0.01 vs NS), without a change in systemic hemodynamics. Spatial Doppler mapping preliminary revealed greater restoration of peripheral flow and decreased hematoma size when compared with NS-treated cords. Across the survival cohort, Hypertonics, when compared to Normal Saline, achieved greater improvement in motor recovery and reduced the number of days until bladder reflex re-establishment (p=0.038). No electrolyte-related complications were observed. CONCLUSIONS: A single HTS bolus delivered within 30 min of contusive SCI significantly improves microvascular perfusion and translates into early locomotor and autonomic benefits in rats. Real-time ultrasonography demonstrates both spatial and temporal perfusion gains, supporting HTS as a readily deployable adjunct to surgical decompression. Ongoing dose-escalation and large-animal studies will define optimal sodium targets and durability of benefit before first-in-human trials.
Fields of Study & Subjects
Spinal Cord Injury Research
Traumatic Brain Injury and Neurovascular Disturbances
Spinal Hematomas and Complications
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 37–37
- Publication date
- 26 March 2026
- Language
- EN